Published in
Elsevier, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 1(135), p. 155-160, 2015
DOI: 10.1016/j.thromres.2014.11.009
Links
Tools
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear
Journal article published in 2015 by
Cassandra P. Loren,
Joseph E. Aslan 
,
Rachel A. Rigg,
Marie S. Nowak,
Laura D. Healy,
András Gruber,
Brian J. Druker,
Owen J. T. McCarty
,
Rachel A. Rigg,
Marie S. Nowak,
Laura D. Healy,
András Gruber,
Brian J. Druker,
Owen J. T. McCarty
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 